Steve Elms

Companies

• Elevation Oncology, Inc.Board member Jun 22, 2022 to now¹
• Marker Therapeutics, Inc.Board member Aug 8, 2019 to now²
• ADMA Biologics (United States)Board member Feb 15, 2012 to now³
• Zosano Pharma CorpBoard member May 21, 2018 to Jun 14, 2021⁴
• Pernix Therapeutics HoldingsBoard member Feb 1, 2012 to May 31, 2016⁵
• T2 Biosystems, Inc.Board member Dec 9, 2015 to Dec 9, 2015⁶
• Cidara TherapeuticsBoard member Apr 14, 2015 to Apr 22, 2015⁷
• AGILE THERAPEUTICS INCBoard member Jan 27, 2015 to Jan 27, 2015⁸
• Ambit BiosciencesBoard member May 15, 2013 to Sep 4, 2014⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABADMA Biologics (United States) ADMA2,143,750 shares¹⁰$23.8M at $11.09Mar 9, 2026
• MTMarker Therapeutics, Inc. MRKR328,338 shares¹¹$367.7K at $1.12Dec 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 6, 2026Bought 7,000 shares at $15.39 of ADMA Biologics (United States)¹⁰
• Mar 5, 2026Bought 7,000 shares at $15.67 of ADMA Biologics (United States)¹⁰
• Feb 9, 2026Granted 10,690 shares of ADMA Biologics (United States)¹²
• Jun 16, 2025Sold 194,749 shares at $20.24 of ADMA Biologics (United States)¹³
• Jun 13, 2025Sold 137,931 shares at $20.82 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 37,541 shares at $5.40 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 51,630 shares at $3.35 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 53,172 shares at $1.67 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 55,000 shares at $2.35 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 15,000 shares at $2.92 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 30,000 shares at $3.89 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 17,500 shares at $4.91 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 53,837 shares at $3.66 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 10,000 shares at $5.00 of ADMA Biologics (United States)¹³
• Jun 13, 2025Exercised options 9,000 shares at $5.96 of ADMA Biologics (United States)¹³
• Jun 12, 2025Sold 92,941 shares at $21.69 of ADMA Biologics (United States)¹³
• Feb 19, 2025Granted 10,889 shares of ADMA Biologics (United States)¹⁴
• Dec 23, 2024Bought 11,085 shares at $3.20 of Marker Therapeutics, Inc.¹¹
• Nov 27, 2024Exercised options 9,000 shares at $10.80 of ADMA Biologics (United States)¹⁵
• Mar 19, 2024Sold 411,829 shares at $6.08 of ADMA Biologics (United States)¹⁶
• Mar 18, 2024Sold 49,887 shares at $6.01 of ADMA Biologics (United States)¹⁶
• Mar 15, 2024Sold 183,008 shares at $6.01 of ADMA Biologics (United States)¹⁷
• Mar 14, 2024Sold 448,276 shares at $6.05 of ADMA Biologics (United States)¹⁷
• Mar 13, 2024Sold 407,000 shares at $6.21 of ADMA Biologics (United States)¹⁷
• Feb 26, 2024Granted 24,040 shares of ADMA Biologics (United States)¹⁸